Barclays PLC reports NII expansion via hedge repricing and a 14% RoTE target from strategic capital rotation. See why BCS ...

The $600 Body Scan 2 will measure 60 biomarkers to assess cardiovascular and metabolic health. The $600 Body Scan 2 will measure 60 biomarkers to assess cardiovascular and metabolic health. is a ...

After your third week, a Factor prepared-meal subscription comes with a Withings Body Comp scale that scans your body-fat percentage. Lord help me. I will admit to being afraid of scales—the kind that ...

Factor is offering a limited-time deal for new customers that includes a free Withings Body Comp scale. The promotion also includes 50% off the first delivery of the meal service. The Withings Body ...

The Ultra BodyScan is Wyze’s most expensive and accurate smart scale. The Ultra BodyScan is Wyze’s most expensive and accurate smart scale. is a senior reporter who’s been covering and reviewing the ...

The present study aimed to determine the psychometric properties (PPs) and confirmatory factor structure of the Opinions about the Gifted and their Education (OGE) as a scale for measuring teacher’s ...

More than 99% of people who went on to suffer a heart attack, stroke or heart failure already had at least one risk factor above optimal level beforehand, reports a large-scale study led by ...

The geriatric depression scale is a self-reported screening survey to help detect depression in older adults. There’s a short version with 15 questions and a long version with 30. The geriatric ...

Scale AI, which helps tech companies prepare data to train their AI models, filed a lawsuit against one of its former sales employees and its rival Mercor on Wednesday. The suit claims the employee, ...

10x Genomics is stepping up to buy Scale Biosciences and its single-cell profiling solutions, with plans to implement them within the company’s Chromium platform. The deal for the recent Fierce ...

Scale AI is cutting 14% of its staff weeks after Meta's $14.3 billion investment in the startup. Interim CEO Jason Droege said in a memo that company ramped up its generative AI capacity "too quickly" ...